Published inReceptor.AIAI meets DEL: Is this the most powerful combo in modern drug discovery?The power of AI may bring DEL screening to the next levelSep 23, 2022Sep 23, 2022
Published inReceptor.AIThe Proof of Excellence: comparative study of Receptor.AI virtual screening technologiesComparative analysis with other techniques for small molecule drug discoveryAug 26, 2022Aug 26, 2022
Published inReceptor.AIDeveloping novel inhibitors of BRD4 to fight leukaemia with RECEPTOR.AI SaaS PlatformCase study of the platform usageAug 15, 2022Aug 15, 2022
Published inReceptor.AIData rules it all in AI-based drug discoveryAutomation of data-related tasks is crucial for the success of big pharma and SME biotech in drug discoveryAug 1, 2022Aug 1, 2022
Published inReceptor.AICan automated AI drug discovery platforms increase the confidence of pharma in AI techniques?Is it possible to overcome the frustration of early adopters of AI drug discovery techniques?Jul 25, 2022Jul 25, 2022
Published inReceptor.AIReceptor.AI “democratizes” automated AI solutions for drug discoveryThe Receptor.AI platform automates the major stages of AI-based drug discovery workflowJul 18, 2022Jul 18, 2022
Published inReceptor.AIPublic launch of the Receptor.AI SaaS platform for drug discoveryAI-accelerated automated drug discovery at very competitive pricesJul 11, 2022Jul 11, 2022
Published inReceptor.AIBeyond the traditional omics: AI insights into RNA modificationsThe patterns of post-transcriptional RNA modifications are complex but AI makes sense of themJul 20, 2021Jul 20, 2021
Published inReceptor.AIWhich animal will cause the next pandemic? AI gives some hintsAI model have found 20,000 unknown associations between the viruses and animal speciesJul 13, 2021Jul 13, 2021
Published inReceptor.AIYou can’t afford clinical trials? Emulate them with AI!AI is providing a breakthrough in drug repurposing by emulating randomized clinical trials on the real-world patient recordsJul 1, 2021Jul 1, 2021